EA200602017A1 - КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ - Google Patents

КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ

Info

Publication number
EA200602017A1
EA200602017A1 EA200602017A EA200602017A EA200602017A1 EA 200602017 A1 EA200602017 A1 EA 200602017A1 EA 200602017 A EA200602017 A EA 200602017A EA 200602017 A EA200602017 A EA 200602017A EA 200602017 A1 EA200602017 A1 EA 200602017A1
Authority
EA
Eurasian Patent Office
Prior art keywords
aerosol inhalation
agonists
composition
propellant
residues
Prior art date
Application number
EA200602017A
Other languages
English (en)
Other versions
EA012583B1 (ru
Inventor
Майкл Эйвен
Original Assignee
Бёрингер Ингельхайм Интернациональ Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34979667&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200602017(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Бёрингер Ингельхайм Интернациональ Гмбх filed Critical Бёрингер Ингельхайм Интернациональ Гмбх
Publication of EA200602017A1 publication Critical patent/EA200602017A1/ru
Publication of EA012583B1 publication Critical patent/EA012583B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

В заявке описана не содержащая пропеллент лекарственная композиция для аэрозольной ингаляции, содержащая одно или несколько соединений общей формулы ()в которой остатки R, R, Rи Хмогут иметь указанные в формуле изобретения и описании значения.
EA200602017A 2004-05-14 2005-05-10 КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ EA012583B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004024452A DE102004024452A1 (de) 2004-05-14 2004-05-14 Aerosolformulierung für die Inhalation von Betaagonisten
PCT/EP2005/005028 WO2005110421A2 (de) 2004-05-14 2005-05-10 Aerosolformulierung für die inhalation von betaagonisten

Publications (2)

Publication Number Publication Date
EA200602017A1 true EA200602017A1 (ru) 2007-06-29
EA012583B1 EA012583B1 (ru) 2009-10-30

Family

ID=34979667

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200602017A EA012583B1 (ru) 2004-05-14 2005-05-10 КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ

Country Status (26)

Country Link
EP (1) EP1809293B1 (ru)
JP (1) JP4620730B2 (ru)
KR (1) KR101288791B1 (ru)
CN (1) CN101056640A (ru)
AR (1) AR049096A1 (ru)
AU (1) AU2005244414B2 (ru)
BR (1) BRPI0511135B8 (ru)
CA (1) CA2564379C (ru)
DE (1) DE102004024452A1 (ru)
DK (1) DK1809293T3 (ru)
EA (1) EA012583B1 (ru)
EC (1) ECSP067004A (ru)
ES (1) ES2575925T3 (ru)
HU (1) HUE027780T2 (ru)
IL (1) IL179218A (ru)
MX (1) MXPA06013216A (ru)
MY (1) MY148403A (ru)
NO (1) NO20065030L (ru)
PE (1) PE20060311A1 (ru)
PL (1) PL1809293T3 (ru)
SG (1) SG152265A1 (ru)
TW (1) TWI356703B (ru)
UA (1) UA87312C2 (ru)
UY (1) UY28891A1 (ru)
WO (1) WO2005110421A2 (ru)
ZA (1) ZA200607462B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
AU2006281449B2 (en) 2005-08-15 2013-01-31 Boehringer Ingelheim International Gmbh Method for producing betamimetics
KR20080067699A (ko) * 2005-11-09 2008-07-21 베링거 인겔하임 인터내셔날 게엠베하 흡입용 에어로졸 제형
UY30543A1 (es) * 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de beta- agonistas
US20110319402A1 (en) * 2008-11-21 2011-12-29 Boehringer Ingelheim International Gmbh Aerosol formulation for the inhalation of beta agonists
CA2738617A1 (en) * 2008-11-21 2011-05-27 Boehringer Ingelheim International Gmbh Aerosol formulation for the inhalation of beta agonists
WO2014056840A1 (en) 2012-10-09 2014-04-17 Boehringer Ingelheim International Gmbh Beta-2-adrenoceptor agonist for the treatment of cough
CN110062625A (zh) 2016-12-12 2019-07-26 勃林格殷格翰国际有限公司 尼达尼布通过与奥达特罗共给予用于治疗间质性肺病的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3134590A1 (de) * 1981-09-01 1983-03-10 Boehringer Ingelheim KG, 6507 Ingelheim Neue benzo-heterocyclen
US4460581A (en) * 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
JPH0637388B2 (ja) * 1986-02-17 1994-05-18 千寿製薬株式会社 水性液剤
GB9405019D0 (en) * 1994-03-15 1994-04-27 Smithkline Beecham Plc Novel compounds
DE10253282A1 (de) * 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung
ES2523518T3 (es) * 2004-04-22 2014-11-26 Boehringer Ingelheim International Gmbh Nuevas combinaciones farmacológicas para el tratamiento de enfermedades de las vías respiratorias
DE102004019539A1 (de) * 2004-04-22 2005-11-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von Atemwegserkrankungen
DE102004024451A1 (de) * 2004-05-14 2005-12-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverformulierungen für die Inhalation, die Enantiomerenreine Betaagonisten enthalten
DE102004024454A1 (de) * 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel

Also Published As

Publication number Publication date
AU2005244414A1 (en) 2005-11-24
UA87312C2 (ru) 2009-07-10
EA012583B1 (ru) 2009-10-30
ECSP067004A (es) 2007-02-28
JP4620730B2 (ja) 2011-01-26
PL1809293T3 (pl) 2016-09-30
PE20060311A1 (es) 2006-05-08
TW200608981A (en) 2006-03-16
MY148403A (en) 2013-04-30
EP1809293B1 (de) 2016-03-16
UY28891A1 (es) 2005-12-30
ES2575925T3 (es) 2016-07-04
KR101288791B1 (ko) 2013-07-29
AU2005244414B2 (en) 2010-12-09
NO20065030L (no) 2006-11-30
WO2005110421A3 (de) 2006-03-16
HUE027780T2 (en) 2016-11-28
BRPI0511135B8 (pt) 2021-05-25
CA2564379C (en) 2013-07-30
JP2007537188A (ja) 2007-12-20
DK1809293T3 (en) 2016-06-20
TWI356703B (en) 2012-01-21
IL179218A0 (en) 2007-03-08
BRPI0511135B1 (pt) 2019-11-12
DE102004024452A1 (de) 2005-12-08
MXPA06013216A (es) 2007-02-08
WO2005110421A2 (de) 2005-11-24
EP1809293A2 (de) 2007-07-25
BRPI0511135A (pt) 2007-11-27
CA2564379A1 (en) 2005-11-24
AR049096A1 (es) 2006-06-28
KR20070022084A (ko) 2007-02-23
ZA200607462B (en) 2008-06-25
SG152265A1 (en) 2009-05-29
IL179218A (en) 2012-10-31
CN101056640A (zh) 2007-10-17

Similar Documents

Publication Publication Date Title
EA200602017A1 (ru) КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ
EA200800927A1 (ru) КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ
EA200900267A1 (ru) КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ И СТЕРОИДОВ
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
DK1934174T3 (da) Azetidiner som MEK inhibitorer til behandling af proliferative sygdomme
HRP20080564T3 (en) Dihydrotetrabenazines and pharmaceutical compositions containing them
SE0301700D0 (sv) Novel compounds
ATE430747T1 (de) 2-pyrimidinyl-pyrazolopyridin-erbb- kinaseinhibitoren
UA91027C2 (ru) ИНГИБИТОРЫ ВЗАИМОДЕЙСТВИЯ МЕЖДУ MDM2 И р53
ATE433447T1 (de) Pyrimiidinverbindungen
EA200601837A1 (ru) Бензоксазины для лечения заболеваний дыхательных путей
WO2006007448A3 (en) Pharmaceutical co-crystal compositions and related methods of use
TW200800999A (en) Novel compounds
TW200745161A (en) Stable antibody formulation
SE0302811D0 (sv) Novel compounds
DK1863812T3 (da) Dipeptidylpeptidase-IV-inhiberende forbindelser, fremgangsmåder til fremstilling af de samme og farmaceutiske sammensætninger indeholdende de samme som aktive midler
PL1877390T3 (pl) Związki benzizoksazolopiperazynowe i sposoby ich stosowania
UY28348A1 (es) Compuestos novedosos
DE60314623D1 (de) Substituierte pyrazolopyrimidine
EA200800542A1 (ru) Пиридинаминосульфонилзамещенные бензамиды в качестве ингибиторов цитохрома р450 3а4 (cyp3a4)
TW200736227A (en) New compounds III
TW200716529A (en) New compounds II
TW200621160A (en) Anti-termite agent
EA200801414A1 (ru) Кальцилитические соединения
EA200601855A1 (ru) Гербицидоактивные 3-амино-2-тиометилбензоилпиразолы

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM

ND4A Extension of term of a eurasian patent
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY